Literature DB >> 289407

Differentiation of myeloid leukaemic cells: new possibilities for therapy.

M Baccarani, S Tura.   

Abstract

Mesh：

Substances：

Year:  1979        PMID： 289407     DOI： 10.1111/j.1365-2141.1979.tb01157.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  13 in total

1.  In vitro evidence for dose-dependent cytotoxicity as the predominant effect of low dose Ara-C on human leukemic and normal marrow cells.

Authors:  C S Chan; G P Schechter
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Clinical trial of low-dose Ara-C in the treatment of acute leukemia and myelodysplasia.

Authors:  U Jehn; R De Bock; C Haanen
Journal:  Blut       Date:  1984-05

3.  Low-dose cytosine-arabinoside in the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

Authors:  H J Weh; R Zschaber; D K Hossfeld
Journal:  Blut       Date:  1984-04

4.  Low-dose Ara-C in the treatment of acute leukemia. Cytotoxicity or differentiation induction?

Authors:  D Hoelzer; A Ganser; B Anger; E Seifried; H Heimpel
Journal:  Blut       Date:  1984-04

5.  In vitro exposure of leukemic cells to low concentration Arabinosyl Cytosine: no evidence of differentiation inducing activity.

Authors:  M R Motta; M Baccarani; S Rizzi; R Fanin; G Fasola; C Poluzzi; S Tura
Journal:  Blut       Date:  1987-05

6.  Electron microscopic and immunohistochemical observations of differentiation of human myeloid leukemia line, PL-21.

Authors:  I Kubonishi; Y Ohtsuki; T Miyagi; S Yoshimoto; T Akagi; I Miyoshi
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

7.  Induction of erythroid differentiation by the anthracycline antitumor antibiotic pyrromycin.

Authors:  G Steinheider; A Schaefer; J Westendorf; H Marquardt
Journal:  Cell Biol Toxicol       Date:  1988-03       Impact factor: 6.691

8.  Cell differentiation and malignancy.

Authors:  L Sachs
Journal:  Cell Biophys       Date:  1986-12

9.  Is there still a role for low-dose cytosine arabinoside in de novo acute myeloid leukemia in the elderly? A report on 77 cases.

Authors:  L Detourmignies; E Wattel; J L Laï; F Bauters; P Fenaux
Journal:  Ann Hematol       Date:  1993-05       Impact factor: 3.673

Review 10.  Managing myelodysplastic symptoms in elderly patients.

Authors:  R Ria; M Moschetta; A Reale; G Mangialardi; A Castrovilli; A Vacca; F Dammacco
Journal:  Clin Interv Aging       Date:  2009-11-18       Impact factor: 4.458
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.